Title 21 Job Opportunities
The 21st Century Cures Act was enacted on December 13, 2016 and Section 3072 of the Act grants the Commissioner of Food and Drugs the authority to appoint and set the annual rate of pay for outstanding and qualified candidates to scientific, technical, or professional positions that support the development, review, and regulation of medical products. The FY23 Food and Drug Omnibus Reform Act expanded this authority further amending Title 21 to include cross-cutting operational positions and individuals that support the development review and regulation of food and cosmetics in addition medical products. (codified into Title 21 of the United States Code (21 US Code 379d-3a).
The positions listed below are being filled under Title 21. The candidate selected for these positions will serve under a career or career-conditional appointment and be paid under the provisions of the authority. Additional information on 21st Century Cures Act can be found here
Title 21 Open Vacancies
Lead Biologist
Center for Drug Evaluation and Research (CDER)
Closing date: March 1, 2024
Lead Pharmacologist/Toxicologist
Center for Drug Evaluation and Research (CDER)
Closing date: March 1, 2024
Pharmacist
Center for Drug Evaluation and Research (CDER)
Closing date: March 5, 2024
Web and Graphics Branch Chief
Center for Devices and Radiological Health (CDRH)
Closing date: March 15, 2024
Data Engineer (Data Scientist)
Center for Devices and Radiological Health (CDRH)
Closing date: March 14, 2024
Physician (Transfusion Medicine)
Center for Biologics Evaluation and Research (CBER)
Closing date: March 17, 2024
Division Director, (Clinical Evaluation & Hematology)
Center for Biologics Evaluation and Research (CBER)
Closing date: March 17, 2024
Division Director, DE (Regulatory Specialist)
Center for Food Safety and Applied Nutrition (CFSAN)
Closing date: February 28, 2024
Mathematical Statistician Team Lead
Center for Biologics Evaluation and Research (CBER)
Closing date: February 23, 2024
Supervisory Mathematical Statistician
Center for Drug Evaluation and Research (CDER)
Closing Date: February 23, 2024
Health Communications Specialist
Center for Devices and Radiological Health (CDRH)
Closing date: March 9, 2024
Regulatory Counsel
Center for Drug Evaluation and Research (CDER)
Closing Date: March 8, 2024
Regulatory Counsel
Center for Drug Evaluation and Research (CDER)
Closing Date: March 8, 2024
Physician
Center for Biologics Evaluation and Research (CBER)
Closing date: Open continuously; applications will be reviewed periodically
Business Informaticist (Data Integration)
Center for Biologics Evaluation and Research (CBER)
Closing date: February 15, 2024
International Relations Specialist
Office of the Commissioner (OC)
Closing Date: February 26, 2024
Biologist
Center for Drug Evaluation and Research (CDER)
Closing Date: February 23, 2024
Pharmacologist/Toxicologist
Center for Drug Evaluation and Research (CDER)
Closing Date: February 23, 2024
Technical Information Specialist
Center for Biologics Evaluation and Research (CBER)
Closing Date: February 22, 2024
Investigator II/Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 22, 2024
Computer Scientist
The Center for Drug Evaluation and Research (CDER)
Closing Date: April 19, 2024
Associate Director of Labeling
Center for Biologics Evaluation and Research (CBER)
Closing date: February 16, 2024
Investigator II
Office of Regulatory Affairs (ORA)
Closing date: July 10, 2024
Investigator II
Office of Regulatory Affairs (ORA)
Closing date: May 31, 2024
Investigator II
Office of Regulatory Affairs (ORA)
Closing date: April 11, 2024
Investigator II
Office of Regulatory Affairs (ORA)
Closing date: April 10, 2024
Physician, Office of Therapeutic Products (OTP)
Center for Biologics Evaluation and Research (CBER)
Open continuously; applications will be reviewed periodically
Physician
Center for Biologics Evaluation and Research (CBER)
Open continuously; applications will be reviewed periodically.